Biofrontera
BFRI
13 hedge funds and large institutions have $413K invested in Biofrontera in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.01% less ownership
Funds ownership: 0.16% → 0.15% (-0.01%)
19% less funds holding
Funds holding: 16 → 13 (-3)
21% less capital invested
Capital invested by funds: $520K → $413K (-$107K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$7.8K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$42 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$20.9K |
| 2 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
-$10.9K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$3.72K |
| 4 |
VF
VitalStone Financial
Shavano Park,
Texas
|
-$2K |
| 5 |
QC
Quent Capital
New York
|
-$1.09K |
BFRI Hedge Fund Activity: Q2 2023 in Review
13 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2023, worth a combined $413K — down 21% from $520K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BFRI and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $7.8K. The largest seller was BlackRock, cutting an estimated $20.9K.
- 13 institutional investors held Biofrontera (BFRI) as of Q2 2023, down from 16 in Q1 2023.
- Funds reported $413K of Biofrontera stock for Q2 2023, down 21% quarter-over-quarter.
- 1 fund opened new Biofrontera positions in Q2 2023 and 4 closed out, a net change of -3 holders.
- The largest Biofrontera buyer in Q2 2023 was Renaissance Technologies, an estimated $7.8K added.
- The largest Biofrontera seller in Q2 2023 was BlackRock, an estimated $20.9K sold.
Based on aggregated 13F filings for Q2 2023.